可怖
发表于 2025-3-21 17:22:13
书目名称Neuroimmunology影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0664101<br><br> <br><br>书目名称Neuroimmunology影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0664101<br><br> <br><br>书目名称Neuroimmunology网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0664101<br><br> <br><br>书目名称Neuroimmunology网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0664101<br><br> <br><br>书目名称Neuroimmunology被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0664101<br><br> <br><br>书目名称Neuroimmunology被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0664101<br><br> <br><br>书目名称Neuroimmunology年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0664101<br><br> <br><br>书目名称Neuroimmunology年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0664101<br><br> <br><br>书目名称Neuroimmunology读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0664101<br><br> <br><br>书目名称Neuroimmunology读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0664101<br><br> <br><br>
Texture
发表于 2025-3-21 20:38:39
http://reply.papertrans.cn/67/6642/664101/664101_2.png
Cpr951
发表于 2025-3-22 03:22:59
http://reply.papertrans.cn/67/6642/664101/664101_3.png
Wernickes-area
发表于 2025-3-22 05:01:45
https://doi.org/10.1007/978-3-030-61883-4Neuroimmunology; Multiple Sclerosis; Autoimmune Neurology; Immunology; Central Nervous System inflammato
声音刺耳
发表于 2025-3-22 09:06:12
http://reply.papertrans.cn/67/6642/664101/664101_5.png
寒冷
发表于 2025-3-22 13:51:18
http://reply.papertrans.cn/67/6642/664101/664101_6.png
Axon895
发表于 2025-3-22 19:29:47
Neuroimaging Modalities in Neuroimmunologyple sclerosis (MS). MRI is highly sensitive to visualize white matter signal abnormalities on T2-weighted images, and the characteristic appearance of demyelinating lesions has become well recognized. However, MRI is not pathologically specific, and differentiating MS from other (non-MS) conditions
comely
发表于 2025-3-22 21:21:27
Clinical Trial Design in Neuroimmunologyd great insights into these conditions resulting in the approval of disease-modifying therapies (DMTs) for multiple sclerosis (MS) and neuromyelitis optica spectrum disease (NMOSD) along with symptomatic therapies such as dalfampridine. Treatment of relapsing-remitting MS (RRMS) has seen dramatic ch
integrated
发表于 2025-3-23 02:25:43
Concepts of Immune Therapy and Disease Managementd should be promptly recognized for early treatment and optimization of chronic immunomodulating or immunosuppressing therapies to avoid disability accumulation over time. Detection of subclinical activity using paraclinical testing also warrants a change in treatment and should be part of the monit
临时抱佛脚
发表于 2025-3-23 08:11:02
http://reply.papertrans.cn/67/6642/664101/664101_10.png